Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

TPEX:4186 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	157.98	140.74	106.32	182.14	158.56	159.7
Cash & Short-Term Investments	157.98	140.74	106.32	182.14	158.56	159.7
Cash Growth	39.06%	32.37%	-41.62%	14.87%	-0.71%	-32.59%
Accounts Receivable	87.91	98.26	97.56	51.84	62.43	67.29
Other Receivables	-	-	-	-	0.25	0.13
Receivables	87.91	98.26	97.56	51.84	62.68	67.43
Inventory	21.61	22.9	18.7	21.17	23.42	24.11
Prepaid Expenses	7.34	-	4.15	3	-	-
Other Current Assets	1.44	4.87	1.71	1.16	15.48	16.42
Total Current Assets	276.28	266.76	228.45	259.3	260.13	267.66
Property, Plant & Equipment	250.64	251.46	234.03	246.27	255.02	256.79
Long-Term Investments	87.4	88.21	78.23	93.9	72.94	67.75
Other Intangible Assets	0.16	0.17	0.2	0.22	3.53	10.14
Long-Term Deferred Tax Assets	10.75	10.75	9.88	9.81	8.82	8.73
Other Long-Term Assets	125.15	129.39	125.65	139.08	106.34	102.67
Total Assets	750.39	746.74	676.42	748.57	706.77	713.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.05	13.52	8.48	16.65	14.55	11.55
Accrued Expenses	-	32.66	-	-	-	-
Short-Term Debt	200	180	140	180	130.95	107.86
Current Portion of Long-Term Debt	-	15.55	24.54	36.52	35.71	20.92
Current Portion of Leases	2.31	2.89	4.38	3.83	4.65	4.4
Current Unearned Revenue	26.19	25.92	26.86	26.77	26.06	60.98
Other Current Liabilities	44.61	1.69	34.63	53.05	31.15	39.36
Total Current Liabilities	281.16	272.23	238.88	316.82	243.07	245.08
Long-Term Debt	73.08	62.38	58.65	83.18	103.27	108.08
Long-Term Leases	4.31	3.31	2.08	3.71	5.12	7.7
Long-Term Unearned Revenue	121.53	121.86	118.54	109.08	109.07	109.63
Pension & Post-Retirement Benefits	-	-	-	-	-	0.79
Long-Term Deferred Tax Liabilities	0.99	0.99	0.85	0.97	0.71	-
Other Long-Term Liabilities	0.87	0.88	0.98	0.89	0.89	1.01
Total Liabilities	481.93	461.64	419.98	514.65	462.13	472.29

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	900	900	900	900	900	900
Additional Paid-In Capital	-	-	-	-	-	0.05
Retained Earnings	-630.03	-613.85	-642.51	-665.72	-654.95	-658.6
Comprehensive Income & Other	-1.51	-1.06	-1.05	-0.36	-0.4	-
Shareholders' Equity	268.46	285.1	256.44	233.92	244.64	241.45
Total Liabilities & Equity	750.39	746.74	676.42	748.57	706.77	713.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	279.69	264.12	229.64	307.24	279.7	248.97
Net Cash (Debt)	-121.71	-123.38	-123.32	-125.11	-121.15	-89.27
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.41	-1.37	-1.37	-1.39	-1.35	-0.99
Filing Date Shares Outstanding	89.89	90	90	90	90	90
Total Common Shares Outstanding	89.89	90	90	90	90	90
Working Capital	-4.88	-5.47	-10.44	-57.52	17.07	22.58
Book Value Per Share	2.99	3.17	2.85	2.60	2.72	2.68
Tangible Book Value	268.3	284.92	256.25	233.7	241.11	231.31
Tangible Book Value Per Share	2.98	3.17	2.85	2.60	2.68	2.57
Land	-	134.47	127.13	127.13	127.13	118.51
Buildings	-	94.49	81.12	81.12	81.12	77.61
Machinery	-	237.43	228.15	226.64	219.34	217.25

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error